financetom
Business
financetom
/
Business
/
Market Chatter: Brazil's PicPay Plans Nasdaq IPO Next Year
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Brazil's PicPay Plans Nasdaq IPO Next Year
Oct 2, 2024 10:53 PM

07:18 AM EDT, 10/02/2024 (MT Newswires) -- Brazilian digital bank PicPay plans to hire financial firms to conduct an initial public offering on Nasdaq next year, Reuters reported Wednesday, citing two people familiar with the matter.

This is the second time PicPay aims to list its shares in the US, having previously abandoned plans for a Nasdaq IPO in 2021 due to market headwinds, the report said.

The company has not formally chosen any investment banks for the consortium, but it plans to work with Citigroup ( C ) among others as the bank has been part of its IPO discussions since 2021, the report said.

PicPay has not decided the size of the IPO yet and wants it to be "only as big as necessary," the report quoted the sources as saying.

Funds raised from the IPO are expected to help the company expand its operations in Brazil, the report said.

PicPay did not immediately respond to MT Newswires' request for comment on the matter.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 61.51, Change: -0.30, Percent Change: -0.49

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Kura Scores A Big Win As FDA Approves Its New Leukemia Pill
Kura Scores A Big Win As FDA Approves Its New Leukemia Pill
Nov 14, 2025
On Thursday, the U.S. Food and Drug Administration granted full approval to Komzifti (ziftomenib), developed by Kura Oncology Inc. ( KURA ) and Kyowa Kirin Co., Ltd., for treating relapsed or refractory (R/R) acute myeloid leukemia (AML) with a susceptible NPM1 mutation. Komzifti is the first and only once-daily, oral menin inhibitor approved for R/R NPM1-mutated (NPM1-m) AML, a type...
Bloom Energy Stock Jumps Friday: What Investors Need To Know
Bloom Energy Stock Jumps Friday: What Investors Need To Know
Nov 14, 2025
Bloom Energy Corp ( BE ) shares are trading higher Friday, recovering ground after a sharp pullback during the previous session. The fuel-cell maker is attracting buyers stepping in to capitalize on Thursday's dip, which appears to have been driven by broader market volatility rather than company-specific negatives. Here’s what investors need to know. BE stock is racing ahead of...
US STOCKS-S&P 500, Nasdaq regain ground as tech recovers; Fed concerns linger
US STOCKS-S&P 500, Nasdaq regain ground as tech recovers; Fed concerns linger
Nov 14, 2025
* Indexes: Dow down 0.32%, S&P 500 up 0.38%, Nasdaq up 0.68% * Financials drag on Dow but indexes set for weekly gains * Walmart ( WMT ) falls after announcing CEO retirement * Cidara Therapeutics ( CDTX ) soars on Merck's ( MRK ) buyout deal (Updates with mid-morning prices, analyst comment) By Twesha Dikshit and Purvi Agarwal Nov...
JPMorgan Remains Overweight On Block (XYZ): What Investors Need To Know
JPMorgan Remains Overweight On Block (XYZ): What Investors Need To Know
Nov 14, 2025
Block Inc ( XYZ ) shares are trading marginally lower Friday morning, continuing to digest last week’s third-quarter earnings miss. Despite the recent pullback, J.P. Morgan reiterated its Overweight rating on the stock, citing a significant “step-up in product velocity” following the company’s inaugural Cash App Release. Here’s what investors need to know. XYZ stock is trending lower. Track the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved